SOLIDION TECHNOLOGY INC (STI) Fundamental Analysis & Valuation

NASDAQ:STI • US8342122012

Current stock price

6.3 USD
+0.08 (+1.29%)
Last:

This STI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. STI Profitability Analysis

1.1 Basic Checks

  • In the past year STI has reported negative net income.
  • In the past year STI has reported a negative cash flow from operations.
STI Yearly Net Income VS EBIT VS OCF VS FCFSTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -5M -10M -15M -20M -25M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -132.75%, STI is doing worse than 85.87% of the companies in the same industry.
Industry RankSector Rank
ROA -132.75%
ROE N/A
ROIC N/A
ROA(3y)-117.72%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STI Yearly ROA, ROE, ROICSTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • STI has a Gross Margin of 50.00%. This is amongst the best in the industry. STI outperforms 94.57% of its industry peers.
  • STI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STI Yearly Profit, Operating, Gross MarginsSTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. STI Health Analysis

2.1 Basic Checks

  • STI has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, STI has a worse debt to assets ratio.
STI Yearly Shares OutstandingSTI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M
STI Yearly Total Debt VS Total AssetsSTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -40.79, we must say that STI is in the distress zone and has some risk of bankruptcy.
  • STI has a worse Altman-Z score (-40.79) than 90.22% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -40.79
ROIC/WACCN/A
WACCN/A
STI Yearly LT Debt VS Equity VS FCFSTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • STI has a Current Ratio of 0.04. This is a bad value and indicates that STI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • STI has a Current ratio of 0.04. This is amonst the worse of the industry: STI underperforms 90.22% of its industry peers.
  • STI has a Quick Ratio of 0.04. This is a bad value and indicates that STI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • STI has a worse Quick ratio (0.04) than 90.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
STI Yearly Current Assets VS Current LiabilitesSTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. STI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 98.31% over the past year.
EPS 1Y (TTM)98.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. STI Valuation Analysis

4.1 Price/Earnings Ratio

  • STI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STI Price Earnings VS Forward Price EarningsSTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STI Per share dataSTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STI Dividend Analysis

5.1 Amount

  • No dividends for STI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STI Fundamentals: All Metrics, Ratios and Statistics

SOLIDION TECHNOLOGY INC

NASDAQ:STI (4/2/2026, 8:00:01 PM)

6.3

+0.08 (+1.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-20
Earnings (Next)04-14
Inst Owners4.12%
Inst Owner Change183.05%
Ins Owners47.34%
Ins Owner Change0.39%
Market Cap47.06M
Revenue(TTM)13.40K
Net Income(TTM)-6.75M
Analysts72.4
Price TargetN/A
Short Float %16.33%
Short Ratio4.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3512.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0
BVpS-2.33
TBVpS-2.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -132.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50%
FCFM N/A
ROA(3y)-117.72%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -40.79
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-149.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-144.18%
OCF growth 3YN/A
OCF growth 5YN/A

SOLIDION TECHNOLOGY INC / STI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SOLIDION TECHNOLOGY INC?

ChartMill assigns a fundamental rating of 0 / 10 to STI.


What is the valuation status for STI stock?

ChartMill assigns a valuation rating of 0 / 10 to SOLIDION TECHNOLOGY INC (STI). This can be considered as Overvalued.


How profitable is SOLIDION TECHNOLOGY INC (STI) stock?

SOLIDION TECHNOLOGY INC (STI) has a profitability rating of 1 / 10.